Roger Dansey
Director/Board Member bij INOVIO PHARMACEUTICALS, INC.
Vermogen: 49 732 $ op 31-03-2024
Profiel
Op dit moment bekleedt Roger D. Dansey de functie van Chief Medical Officer bij Seagen Inc. In het verleden bekleedde Dr. Dansey de positie van Vice President-Oncology Clinical Research bij Gilead Sciences, Inc. en SVP & Head-Therapeutic Area bij Merck Research Laboratories Massachusetts LLC. Dr. Dansey is gepromoveerd aan de Universiteit van de Witwatersrand.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
16-11-2023 | 3 583 ( 0.02% ) | 49 732 $ | 31-03-2024 |
Actieve functies van Roger Dansey
Bedrijven | Functie | Begin |
---|---|---|
INOVIO PHARMACEUTICALS, INC. | Director/Board Member | 13-05-2021 |
KRONOS BIO, INC. | Director/Board Member | 20-04-2023 |
Eerdere bekende functies van Roger Dansey
Bedrijven | Functie | Einde |
---|---|---|
SEAGEN INC. | Chief Executive Officer | 09-11-2022 |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The private company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Corporate Officer/Principal | 01-04-2018 |
MERCK & CO., INC. | Corporate Officer/Principal | 01-04-2018 |
GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01-01-2014 |
Opleiding van Roger Dansey
University of the Witwatersrand | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 4 |
---|---|
GILEAD SCIENCES, INC. | Health Technology |
MERCK & CO., INC. | Health Technology |
INOVIO PHARMACEUTICALS, INC. | Health Technology |
KRONOS BIO, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Seagen Inc.
Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The private company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Health Technology |